Year: 2019

BerkeleyWellness.com has posted a version of my interview with Dr Steve Olson. He’s the Kaiser Permanente guy who is revamping the health system’s approach to ME/CFS, which is what they are now calling the disease. Dr Olson is planning to attend this week’s research gathering at the National Institutes of Health, so undoubtedly that will…

The recent Reuters article about the illness, or cluster of illnesses, variously called CFS, ME, CFS/ME and ME/CFS was problematic for many reasons. One of them was the information included from the US Centers for Disease Control and Prevention. In explaining why the CDC dropped its longstanding recommendations for cognitive behavior therapy and graded exercise…

This morning I sent the following e-mail to Kate Kelland, the Reuters reporter who wrote last week’s story about horrible patients and horrible me, and about how all this horribleness is affecting Professor Michael Sharpe. I cc’d Professor Racaniello and the two Reuters editors listed on the story. Hi, Kate– Congratulations on last week’s piece.…

Matthew Hotopf is a professor of general medicine psychiatry at King’s College London. He served as a peer-reviewer for a study by Bristol University investigators that was published in BMJ Open in 2011. The study involved whether school absences could be used to identify cases of diagnosed CFS/ME (as the study called the illness). As…

Update: When I posted earlier today, I also meant to update what was happening with the exercise review. On March 8, Cochrane announced, through a notice appended to the review, that the authors would submit another revision in May. (Cochrane has already rejected a previous revision submitted last fall.) That is also the month when…

Over the years, I’ve slammed U.S. medical and health care institutions that have championed the GET/CBT treatment paradigm for the illness or cluster of illnesses variously known as ME, CFS, ME/CFS or CFS/ME. I have done this both before and after the U.S. Centers for Disease Control and Prevention removed its own recommendations for the…

Boy, it’s hard to keep up with all the stupid studies coming out! But that’s no reason not to take a look at a couple of them. (In both cases, I’m just making a few comments. Much more could be said about each of these studies. You can read more about them on the Science…

Update (later on March 4): Because Royal United Hospitals Bath suggested that I “redirect” my request for documents back to Bristol University, that’s what I did. Earlier today, I sent an e-mail to Bristol’s director of legal services. Here’s what I wrote: As you likely remember, I have raised concerns about a number of studies…

In January, I wrote about the problematic online training course developed by the Royal College of General Practitioners and touted by Steve Brine MP as addressing the “misconceptions” about ME (or CFS/ME, as the online course calls the illness). The lead author of the course was Carolyn Chew-Graham, a professor of general practice research at…

The situation at Cochrane appears to remain fluid. Last week, the organization posted a notice that it is seeking a new editor-in-chief. The current occupant of the position, Dr David Tovey, is leaving in May. Dr Tovey has been at Cochrane for a decade, so this move could easily have been a long-planned departure. Since…

This morning, I sent the following message to Dr Fiona Godlee, editor-in-chief of The BMJ and editorial director of BMJ. The subject heading: “My remaining concerns…” Dear Fiona— Thank you for the quick changes to Nigel Hawkes’ BMJ news story about the UK Heath Research Authority’s letter on the PACE trial. I appreciate the addition…

After this month’s release of the Health Research Authority’s PACE analysis, Professor Michael Sharpe sent e-mails to at least two US publications requesting a retraction or major correction of critical articles. Professor Sharpe’s e-mails accused the writers involved of suggesting that PACE was “fraudulent.” This accusation was not true. In both cases, the writers had…